Paquette, M. A., Foley, K., Brudney, E. G., Meshul, C. K., Johnson, S. W., & Berger, S. P. (2009). The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism.
Citação norma ChicagoPaquette, Melanie A., Katherine Foley, Elizabeth G. Brudney, Charles K. Meshul, Steven W. Johnson, and S. Paul Berger. The Sigma-1 Antagonist BMY-14802 Inhibits L-DOPA-induced Abnormal Involuntary Movements By a WAY-100635-sensitive Mechanism. 2009.
MLA引文Paquette, Melanie A., et al. The Sigma-1 Antagonist BMY-14802 Inhibits L-DOPA-induced Abnormal Involuntary Movements By a WAY-100635-sensitive Mechanism. 2009.
警告:這些引文格式不一定是100%准確.